Baricitinib 2 mg, 4 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2 mg, 4 mg
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
Category: Anti Covid Medicines
Baricitinib (Olumiant®) is a JAK inhibitor used for rheumatoid arthritis and COVID-19 treatment in hospitalized adults, approved in the US and EU. Available in 1 mg, 2 mg, and 4 mg tablets, it’s sourced globally via PharmaB2B platforms. Connect with GMP-certified manufacturers offering Baricitinib for bulk supply, tenders, and institutional procurement, with full regulatory documentation and global export support.
Product Description: Baricitinib, marketed as Olumiant® by Eli Lilly, is a JAK inhibitor approved in the US and EU for rheumatoid arthritis and authorized for COVID-19 treatment in hospitalized adults. Available in 1 mg, 2 mg, and 4 mg oral tablets, it helps reduce inflammation and cytokine storms in severe COVID-19 cases. Through leading PharmaB2B platforms, global buyers can source Olumiant or Baricitinib generics from GMP-certified manufacturers in India, China, and Bangladesh. Ideal for hospital tenders and bulk procurement, Baricitinib is widely distributed with full regulatory support, competitive pricing, and fast international shipping.
Baricitinib — third party manufacturing & bulk supply
Baricitinib 2 mg, 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Baricitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Baricitinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Nirmatrelvir / Ritonavir Tablet
Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Tocilizumab
Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details
Favipiravir Tablet
Strength:
200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
